ANAVEX LIFE SCIENCES CORP. Other Income
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Other Income of $1.09 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Income Statement › Other Income
us-gaap:OtherIncome · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. other income for the quarter ending 2026-06-30 was $1.09M, a 10.61% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other income for the quarter ending 2026-03-31 was $1.15M, a 12.98% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other income for the quarter ending 2025-12-31 was $1.12M, a 24.44% decline year-over-year.
- ANAVEX LIFE SCIENCES CORP. other income for the quarter ending 2025-09-30 was $1.02M.
- ANAVEX LIFE SCIENCES CORP. other income for fiscal 2025 was $5.03M, a 49.05% decline from fiscal 2024.
- ANAVEX LIFE SCIENCES CORP. other income for fiscal 2024 was $9.88M, a 19.58% increase from fiscal 2023.
- ANAVEX LIFE SCIENCES CORP. other income for fiscal 2023 was $8.26M.
- ANAVEX LIFE SCIENCES CORP. other income for fiscal 2021 was $443.83K.
| Period end | Other Income 3 month | Other Income 6 month | Other Income 9 month | Other Income 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.09M 10-Q · filed 2026-08-28 | $2.23M derived: sum of 2 quarters · filed 2026-08-28 | $3.35M 10-Q · filed 2026-08-28 | $4.37M derived: sum of 4 quarters · filed 2026-08-28 |
| 2026-03-31 | $1.15M 10-Q · filed 2026-08-28 | $2.25M 10-Q · filed 2026-08-28 | $3.28M derived: sum of 3 quarters · filed 2026-08-28 | $4.50M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-12-31 | $1.12M 10-Q · filed 2026-02-09 | $2.14M derived: sum of 2 quarters · filed 2026-08-28 | $3.35M derived: sum of 3 quarters · filed 2026-08-28 | $4.67M derived: sum of 4 quarters · filed 2026-08-28 |
| 2025-09-30 | $1.02M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-08-28 | $2.23M derived: sum of 2 quarters · filed 2026-08-28 | $3.55M derived: sum of 3 quarters · filed 2026-08-28 | $5.03M 10-K/A · filed 2026-08-28 |
| 2025-06-30 | $1.22M 10-Q · filed 2026-08-28 | $2.53M derived: sum of 2 quarters · filed 2026-08-28 | $4.01M 10-Q · filed 2026-08-28 | |
| 2025-03-31 | $1.32M 10-Q · filed 2026-08-28 | $2.80M 10-Q · filed 2026-08-28 | ||
| 2024-12-31 | $1.48M 10-Q · filed 2026-02-09 | |||
| 2024-09-30 | $9.88M 10-K/A · filed 2026-08-28 | |||
| 2023-09-30 | $8.26M 10-K/A · filed 2026-08-28 | |||
| 2021-09-30 | $443.83K 10-K · filed 2021-11-24 | |||
| 2020-09-30 | $0.00 10-K · filed 2021-11-24 | |||
| 2018-09-30 | $2.15M 10-K · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |